Results 141 to 150 of about 7,186 (171)

[Clinicopathological Characteristics of Cervical Neuroendocrine Carcinoma and Their Relationship With Prognosis]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Lan T, Yao X, Zhou X, Shi L, Hou J, Zhou C, Liu Y, Shi M.   +7 more
europepmc   +1 more source

[Overexpression of lncRNA SNHG12 promotes docetaxel resistance of prostate cancer cells by activating PI3K/AKT signaling <i>via</i> interacting with ELAVL1]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhao C, Li W, Zheng B, Wang G, Xiao Z, Li Y.   +5 more
europepmc   +1 more source

[Research Progress on Immunosenescence in Elderly Patients 
with Advanced Non-small Cell Lung Cancer and Its Immunotherapy]. [PDF]

Zhongguo Fei Ai Za Zhi
Wang N, Luo Y, Lu H, Cui S, Zhao K, Kong F.   +5 more
europepmc   +1 more source

[Construction and Clinical Validation of a Risk Early Warning Model for Mechanical Ventilation-Associated Pneumonia in Older Patients With Lung Cancer]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Wang Z, Shi M, Zhao P, Zhou Y, Zhang Z, Qu G, Fang X.   +6 more
europepmc   +1 more source

[Role and Mechanism of Hyaluronic Acid-modified Milk Exosomes 
in Reversing Pemetrexed Resistance in Lung Adenocarcinoma Cells]. [PDF]

Zhongguo Fei Ai Za Zhi
Wu L, Lei J, Li H.
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and treatment of human immunodeficiency virus infection related diffuse large B cell lymphoma (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association, Lymphoma Integrative Rehabilitation Professional Committee of Chinese Anti-Cancer Association (CACA), Central and Western China AIDS Lymphoma League (CALL), Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO).   +5 more
europepmc   +1 more source

[Clinical Characteristics, MAML2 Gene Rearrangement and Prognosis 
of Pulmonary Mucoepidermoid Carcinoma]. [PDF]

Zhongguo Fei Ai Za Zhi
Bai J, Yan M, Guo L, Lei Z, Liu W, Zou Z, Li J, Zheng Y.   +7 more
europepmc   +1 more source

[How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang Y.
europepmc   +1 more source